Ablynx raises US$230mLatest NewsBelgian nanobody producer Ablynx closes an initial public offering of American Depositary Shares at Nasdaq totalling US$200m plus a fully exercised greenshoe option amounting aggregate gross proceeds to US$230. Read more 30 October 2017 https://european-biotechnology.com/wp-content/uploads/2024/04/Ablynx.jpg 1413 1920 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2017-10-30 06:54:002017-10-30 06:54:00Ablynx raises US$230m